title: Editorial Commentary: Toward New Tools to Assess Rare Invasive Fungal Diseases in Critically Ill Patients.
authors.affiliation: EA7426, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, bioMérieux S.A.; "Pathophysiology of injury-induced immunosuppression (PI3)".|Hospices Civils de Lyon, Burn ICU, Anesthesia and Critical Care Medicine Department, Hôpital E. Herriot, Lyon.
authors.forename: Julien
authors.initials: J
authors.lastname: Textoris
authors.affiliation: Medical Diagnostic Discovery Department, bioMérieux S.A., Grenoble.
authors.forename: Javier
authors.initials: J
authors.lastname: Yugueros-Marcos
authors.affiliation: Medical Affairs Department, bioMérieux S.A., Marcy l'étoile, France.
authors.forename: Françoise
authors.initials: F
authors.lastname: Gay-Andrieu
mesh_terms: D000935:Antifungal Agents; D001228:Aspergillosis; D016638:Critical Illness; D006801:Humans; D007362:Intensive Care Units; D000072742:Invasive Fungal Infections
chemical_list: D000935:Antifungal Agents
keywords: ICU; PCR; biomarker; diagnostic; mucormycosis